Comparison of Serum Lipid Profiles Between Normal Controls and Breast Cancer Patients

Overview

Journal J Lab Physicians

Specialty Pathology

Date 2013 Sep 10

PMID 24014967

Citations 31

Authors

Pikul Laisupasin

Warayupa Thompat

Saowakon Sukarayodhin

Adisak Sornprom

Yuttana Sudjaroen

Affiliations

Soon will be listed here.

Abstract

Background: Researchers have reported association of plasma/serum lipids and lipoproteins with different cancers. Increase levels of circulating lipids and lipoproteins have been associated with breast cancer risk.

Aim: THE AIM OF THIS STUDY IS TO COMPARE SERUM LIPID PROFILES: total-cholesterol (T-CHOL), triglyceride (TG), high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol (LDL-C) and very low density lipoprotein-cholesterol (VLDL-C) between breast cancer patients and normal participants.

Materials And Methods: A total of 403 women in this study were divided into two groups in the period during May 2006-April 2007. Blood samples were collected from 249 patients with early stage breast cancer and 154 normal controls for serum lipid profiles (T-CHOL, TG, HDL-C, LDL-C and VLDL-C) analysis using Hitachi 717 Autoanalyzer (Roche Diagnostic GmbH, Germany). TG, LDL-C and VLDL-C levels in breast cancer group were significantly increased as compared with normal controls group (P < 0.001), whereas HDL-C and T-CHOL levels were not.

Results: The results of this study suggest that increased serum lipid profiles may associate with breast cancer risk in Thai women. Further studies to group important factors including, cancer stages, types of cancer, parity, and menopausal status that may affect to lipid profiles in breast cancer patients along with an investigation of new lipid profiles to clarify most lipid factors that may involve in breast cancer development are needed.

Citing Articles

Routine Blood Tests as Predictive Tools for Differentiating Follicular Thyroid Carcinoma From Follicular Adenoma.

Wang J, Wang J, Liu H, Chen C Int J Gen Med. 2025; 18:733-744.

PMID: 39963518 PMC: 11830949. DOI: 10.2147/IJGM.S502626.

Tumor Lipid Signatures Are Descriptive of Acquisition of Therapy Resistance in an Endocrine-Related Breast Cancer Mouse Model.

Araujo R, Fabris V, Lamb C, Elia A, Lanari C, Helguero L J Proteome Res. 2023; 23(8):2815-2829.

PMID: 37497607 PMC: 11301694. DOI: 10.1021/acs.jproteome.3c00382.

Blood Profiles in the Prediction of Radioiodine Refractory Papillary Thyroid Cancer: A Case-Control Study.

Liu H, Chen Q, Liu B, Wang J, Chen C, Sun S J Multidiscip Healthc. 2023; 16:535-546.

PMID: 36879649 PMC: 9984283. DOI: 10.2147/JMDH.S403045.

Lipid Metabolism Heterogeneity and Crosstalk with Mitochondria Functions Drive Breast Cancer Progression and Drug Resistance.

Azam A, Sounni N Cancers (Basel). 2022; 14(24).

PMID: 36551752 PMC: 9776509. DOI: 10.3390/cancers14246267.

Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?.

Abrahams C, Woudberg N, Lecour S Lipids Health Dis. 2022; 21(1):85.

PMID: 36050733 PMC: 9434835. DOI: 10.1186/s12944-022-01694-y.

References

Hoyer A, Engholm G . Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women. Cancer Causes Control. 1992; 3(5):403-8. DOI: 10.1007/BF00051352. View

Hasija K, Bagga H . Alterations of serum cholesterol and serum lipoprotein in breast cancer of women. Indian J Clin Biochem. 2012; 20(1):61-6. PMC: 3454168. DOI: 10.1007/BF02893044. View

Gerber M, Richardson S, CRASTES DE PAULET P, Pujol H, CRASTES DE PAULET A . Relationship between vitamin E and polyunsaturated fatty acids in breast cancer. Nutritional and metabolic aspects. Cancer. 1989; 64(11):2347-53. DOI: 10.1002/1097-0142(19891201)64:11<2347::aid-cncr2820641126>3.0.co;2-v. View

Boyd N, McGuire V . Evidence of association between plasma high-density lipoprotein cholesterol and risk factors for breast cancer. J Natl Cancer Inst. 1990; 82(6):460-8. DOI: 10.1093/jnci/82.6.460. View

Knapp M, Riches P . Alterations of serum lipids in breast cancer: effects of disease activity, treatment, and hormonal factors. Clin Chem. 1991; 37(12):2093-101. View

Ray G, Husain S . Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem. 2001; 34(1):71-6. DOI: 10.1016/s0009-9120(00)00200-9. View

Bani I, Williams C, Boulter P, Dickerson J . Plasma lipids and prolactin in patients with breast cancer. Br J Cancer. 1986; 54(3):439-46. PMC: 2001617. DOI: 10.1038/bjc.1986.195. View

Patel P, Shah M, Jha F, Raval G, Rawal R, Patel M . Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions. Indian J Cancer. 2004; 41(1):25-31. View

Paley P . Screening for the major malignancies affecting women: current guidelines. Am J Obstet Gynecol. 2001; 184(5):1021-30. DOI: 10.1067/mob.2001.111714. View

10.

Elkhadrawy T, Ahsan H, Neugut A . Serum cholesterol and the risk of ductal carcinoma in situ: a case-control study. Eur J Cancer Prev. 1999; 7(5):393-6. DOI: 10.1097/00008469-199810000-00004. View

11.

Boyd N, McGuire V, Fishell E, Kuriov V, Lockwood G, Tritchler D . Plasma lipids in premenopausal women with mammographic dysplasia. Br J Cancer. 1989; 59(5):766-71. PMC: 2247212. DOI: 10.1038/bjc.1989.160. View

12.

Chyou P, Nomura A, STEMMERMANN G, Kato I . Prospective study of serum cholesterol and site-specific cancers. J Clin Epidemiol. 1992; 45(3):287-92. DOI: 10.1016/0895-4356(92)90089-6. View

13.

Schatzkin A, Hoover R, Taylor P, Ziegler R, Carter C, Albanes D . Site-specific analysis of total serum cholesterol and incident cancer in the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Cancer Res. 1988; 48(2):452-8. View

14.

Davis D, Bradlow H . Can environmental estrogens cause breast cancer?. Sci Am. 1995; 273(4):167-72. View

15.

Forones N, Falcao J, Mattos D, Barone B . Cholesterolemia in colorectal cancer. Hepatogastroenterology. 1998; 45(23):1531-4. View

16.

Kannel W . Status of risk factors and their consideration in antihypertensive therapy. Am J Cardiol. 1987; 59(2):80A-90A. DOI: 10.1016/0002-9149(87)90182-2. View

17.

Agheli N, Therwath A . Nutrition, dietary fat and breast cancer--a review. Indian J Cancer. 1994; 31(4):218-25. View

18.

Lane D, BOATMAN K, McConathy W . Serum lipids and apolipoproteins in women with breast masses. Breast Cancer Res Treat. 1995; 34(2):161-9. DOI: 10.1007/BF00665788. View